STOCK TITAN

Adapthealth (AHCO) Stock News

AHCO Nasdaq

Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.

AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.

Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.

Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has announced its decision to acquire AeroCare Holdings, Inc. for approximately $2.0 billion. The deal includes $1.1 billion in cash and 31 million shares of AdaptHealth common stock. This merger is expected to enhance AdaptHealth's geographic presence, reaching 47 out of 48 continental US states and solidifying partnerships with healthcare providers. The company also raised its 2021 financial guidance significantly, projecting net revenues of $2.05 billion to $2.20 billion and Adjusted EBITDA of $480 million to $515 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.79%
Tags
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) reported strong financial results for Q3 2020, with net revenue of $284.4 million, up 108% year-over-year. The company expanded through acquisitions, enhancing its diabetes management and home medical equipment operations. Despite a net loss of $2.5 million, adjusted EBITDA grew significantly to $53.2 million compared to $31.7 million in Q3 2019. The company increased its 2020 revenue guidance to $1.00-$1.04 billion and provided a strong outlook for 2021, projecting $1.30-$1.40 billion in revenue. CEO Luke McGee highlighted the team's dedication amidst challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has announced the release of its financial results for the third quarter ended September 30, 2020, scheduled for November 4, 2020, before market opening. The management will host a conference call at 8:30 am ET on the same day to discuss the results and business activities. The company serves approximately 1.6 million patients annually through its network of 220 locations across 38 states, providing a range of home medical equipment and services, including sleep therapy and oxygen therapy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
conferences earnings date

FAQ

What is the current stock price of Adapthealth (AHCO)?

The current stock price of Adapthealth (AHCO) is $11.21 as of July 21, 2026.

What is the market cap of Adapthealth (AHCO)?

The market cap of Adapthealth (AHCO) is approximately 1.5B.